NM_000548.5:c.4351C>A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_000548.5(TSC2):c.4351C>A(p.Arg1451Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000373 in 1,607,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000548.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152258Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00000417 AC: 1AN: 239846Hom.: 0 AF XY: 0.00000759 AC XY: 1AN XY: 131682
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1455104Hom.: 0 Cov.: 33 AF XY: 0.00000414 AC XY: 3AN XY: 724156
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152376Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74506
ClinVar
Submissions by phenotype
Tuberous sclerosis 2 Benign:2
- -
- -
Tuberous sclerosis syndrome Uncertain:1
This missense variant replaces arginine with serine at codon 1451 of the TSC2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with tuberous sclerosis complex in the literature. This variant has been identified in 1/239846 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
TSC2-related disorder Uncertain:1
The TSC2 c.4351C>A variant is predicted to result in the amino acid substitution p.Arg1451Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-2134574-C-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R1451S variant (also known as c.4351C>A), located in coding exon 33 of the TSC2 gene, results from a C to A substitution at nucleotide position 4351. The arginine at codon 1451 is replaced by serine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at